BioCatalyst

KarXT — catalyst calendar

3 verified catalyst event(s) referencing KarXT, each linked to its official source. Verified as of 2026-06-22.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-10-05
in 4mo
ESTIMATED
 READOUT
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis As
Phase 3 · Psychosis Associated With Alzheimer's Disease
 Karuna Therapeutics, Inc., a Brist KarXT ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
2026-11-01
in 4mo
ESTIMATED
 READOUT
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic
Phase 3 · Bipolar-I Disorder With Mania or Mania With Mixed Features
 BMY BRISTOL MYERS SQUIBB CO KarXT ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
2026-11-02
in 4mo
ESTIMATED
 READOUT
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic
Phase 3 · Bipolar Disorder Type I With Mania or Mania With Mixed Features
 BMY BRISTOL MYERS SQUIBB CO KarXT ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.